The completion of Phase II expansion doubles the capacity of ambient pallet storage at 15°C to 30°C
Amherst, New Hampshire – November 22, 2022 – Alcami, a leading contract development and manufacturing organization (CDMO), today announced the completion of Phase II of its cGMP biostorage facility located in Amherst, New Hampshire.
“The successful on-time completion of the second phase of this project doubles our biostorage capacity in New Hampshire to approximately 14,000 pallet locations of world-class cGMP storage capacity to support client demand,” commented Timothy Compton, Chief Business Officer at Alcami.
Located in Amherst, N.H., The 160,000 ft² facility features state-of-the-art infrastructure and systems. With the completion of Phase II, 104,000 ft² is now fully operational and ready to support a variety of cGMP client storage needs. Phase III is scheduled for completion in the first quarter of 2023 and will add an additional 56,000 ft² of new capacity.
"This investment further reinforces our commitment to our pharmaceutical clients in support of their increasing demand for secure and reliable cGMP storage requirements.” Added Mr. Compton.
Masy BioServices, acquired by Alcami in 2021, offers cGMP temperature storage from ≤-135˚C to 70˚C, including all ICH stability conditions, for vaccines, biopharmaceuticals, cell banks, tissues, pharmaceutical compounds, raw materials, components, and medical devices.